Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection
Chang-ki Oh, Tomohiro Nakamura, Nathan Beutler, Xu Zhang, Juan Piña-Crespo, Maria Talantova, Swagata Ghatak, Dorit Trudler, Lauren N. Carnevale, Scott R. McKercher, Malina A. Bakowski, Jolene K. Diedrich, Amanda J. Roberts, Ashley K. Woods, Victor Chi, Anil Kumar Gupta, Mia A. Rosenfeld, Fiona L. Kearns, Lorenzo Casalino, Namir Shaabani, Hejun Liu, Ian A. Wilson, Rommie E. Amaro, Dennis R. Burton, John R. Yates, Cyrus Becker, Thomas F. Rogers, Arnab K. Chatterjee, Stuart A. Lipton
Topics & Concepts
S-NitrosylationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Sars virusVirologyCoronavirus disease 2019 (COVID-19)Computational biologyBiologyChemistryMedicineBiochemistryInfectious disease (medical specialty)EnzymeCysteineDiseasePathologyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchNeutrophil, Myeloperoxidase and Oxidative Mechanisms